Description: Research at UC has led to the development of methods of treating conditions associated with lipid oxidation or microbial proliferation which include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. These peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
Issued US Patent 7,273,847
For more information please contact Lynn Briggs at 513-558-3098 or briggsln@ucmail.uc.edu
|
